South Korea's movie theaters are seeing a surge in revenue and admissions, reaching their highest levels since 2020 [1].

This recovery signals a critical turning point for the nation's film industry as it moves past the lingering effects of the pandemic. The rebound suggests that audiences are returning to cinemas in significant numbers, benefiting both local production houses and international distributors.

Domestic cinema has played a primary role in this upswing. The local blockbuster "The King's Warden" ruled sales during the rebound in the first half of the year [1]. This success follows a pattern of strong domestic performances, such as when the sports drama "The Match" topped the Korean box office in April 2025 [3].

International titles are also contributing to the growth. "Toy Story 5" held the number-one spot at the South Korean box office during the weekend of July 3-5 [2]. The combined strength of these Hollywood releases and local hits has created a diversified recovery for theater operators.

Industry observers said that the current trend is a result of a post-pandemic recovery cycle. While domestic films like "The King's Warden" provided the initial momentum for the first-half rebound [1], global franchises continue to maintain high attendance rates in early July [2].

This trend reflects a broader stabilization of the entertainment market. The ability of South Korean cinemas to attract diverse audiences, ranging from those seeking local historical or dramatic narratives to those following global animation series, indicates a healthy appetite for the theatrical experience.

“South Korea's movie theaters are seeing a surge in revenue and admissions, reaching their highest levels since 2020.”

The resurgence of the South Korean box office demonstrates the resilience of the theatrical model against streaming competition. By balancing high-budget domestic content with established global intellectual property, the industry is diversifying its revenue streams to ensure long-term sustainability after years of pandemic-induced decline.